Marcain

Bupivacaine Hydrochloride, the active ingredient in Marcain, is a local anesthetic (amide type) presented as a solution for infiltration use. It provides regional anesthesia for surgical procedures and postoperative pain control in adult patients, working by blocking nerve impulse transmission and delivering prolonged numbness at the targeted site.

GNH USA supplies Marcain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and offers reliable logistics for global distribution.

Marcain is used for regional anesthesia and postoperative pain control across several clinical settings.

- Local infiltration anesthesia: provides numbness of the targeted tissue for minor surgical procedures. - Peripheral nerve block: produces selective sensory and motor blockade of specific peripheral nerves. - Epidural anesthesia: delivers analgesia for labor, obstetric procedures, or lower‑body surgery. - Postoperative pain management: extends analgesic effect to reduce opioid requirements after surgery.

Bupivacaine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Transient burning or stinging at the injection site - Mild dizziness or light‑headedness - Nausea - Metallic taste in the mouth - Transient hypotension

Serious or Rare Side Effects: - Cardiac arrhythmias or conduction block - Seizures - Severe allergic reactions (anaphylaxis) - Persistent motor block - Respiratory depression

When using Marcain, clinicians should observe several safety measures. - Dose selection: tailor to patient weight, age, and procedure type. - Patient monitoring: observe cardiovascular and CNS status during and after administration. - Avoid intravascular injection: aspirate before injection. - Use with caution in patients with hepatic impairment. - Contraindications: known hypersensitivity to bupivacaine or other amide anesthetics. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Bupivacaine can interact with other agents, influencing its safety profile.

Major Interactions (Avoid): - Class I anti‑arrhythmic drugs (e.g., quinidine, procainamide): may enhance cardiotoxicity. - Beta‑blockers (e.g., propranolol): increase risk of severe bradycardia. - General anesthetics (e.g., halothane): potentiate CNS depression.

Moderate Interactions (Monitor Closely): - Opioids (e.g., fentanyl): additive respiratory depression. - Muscle relaxants (e.g., succinylcholine): may prolong neuromuscular block. - Lithium: may increase neurotoxic risk.